Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Value of Measuring Value

Allison Plitman  |  May 11, 2020

Beginning in 2021, the Centers for Medicare & Medicaid Services (CMS) will allow reporting through Merit-Based Incentive Payment System (MIPS) Value Pathways (MVP). According to the CMS, this new participation framework seeks “to move from siloed activities and measures and toward an aligned set of measure options more relevant to a clinician’s scope of practice that is meaningful to patient care.”

Goals of the Quality Payment Program (QPP) are to increase quality of care and improve patient outcomes. According to the CMS, quality measures are useful tools for quantifying processes, outcomes and/or systems that improve the ability to provide effective, safe, efficient, patient-centered, equitable and timely care. Although quality measures are already an integral facet of measuring value and patient outcomes, they haven’t reached their full potential. MVPs still face challenges endemic to quality measurement, such as crafting measures and collecting feedback.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Siloed Data
Lisa Suter, MD, associate professor of medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, Conn., is a leading expert in rheumatology performance measurement and serves as a co-chair of the ACR’s Quality Measures Subcommittee. She has led, directed or consulted on the development of 33 hospital-level outcome measures, three clinician-level outcome measures and 11 clinician-level process measures; 25 are in current or planned use in federal payment programs.

The current difficulty, Dr. Suter believes, is that there are simultaneously too much and too little data. Providers collect large amounts of data during patient visits—health history, vital signs, new prescriptions and more—but those data are not always given context and purpose. “What we have right now is a lot of isolated data,” she says. “There is an overwhelming flood of information that’s not getting harnessed for advanced care. We don’t use it or leverage it.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Measuring for quality aims to bridge that gap by tracking data and leveraging it for a better understanding of how to deliver comprehensive quality care. Quality measures capture and turn data into easily understood statistics, making it easier for previously siloed physicians to share information that increases the quality of care.

Creating Measures & Seeing Outcomes
Quality measures are created using the latest research with important treatment implications; many are based on clinical practice guidelines. Evidence-based guidelines are developed to reduce inappropriate care, minimize geographic variation in practice patterns and enable effective use of healthcare resources. Adherence to practice guidelines is voluntary and cannot guarantee any specific outcome, but they are intended to provide guidance for patterns of practice.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Dr. Lisa SuterMIPSQuality Measures SubcommitteeQuality Payment Program (QPP)

Related Articles

    ACR Members Begin Work on CMS Committees

    March 16, 2018

    TEP In February, Lisa Gale Suter, MD, joined the Technical Expert Panel (TEP) for the Centers for Medicare & Medicaid Services (CMS) Quality Measure Development Plan, supporting the transition to the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs). She was nominated to serve in this role by the ACR. The panel comprises…

    ACR Quality of Care Committee Impresses with Its Recent Productivity

    June 14, 2021

    Over the past 18 months, the ACR’s Quality of Care (QOC) Committee has helped produce an impressive number of resources that will help rheumatologists deliver the best possible care. Working through specific projects supervised under its Criteria, Guideline, Guidance, and Quality Measure subcommittees, the QOC Committee has developed new sets of disease criteria, clinical guidelines,…

    2022 PFS Final Rule for the Quality Payment Program Published

    December 2, 2021

    The ACR highlights essential information for providers for 2022 MIPS reporting in the 2022 Medicare Physician Fee Schedule Final Rule, published Nov. 2.

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences